{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Nipocalimab", "query": { "intervention": "Nipocalimab" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Nipocalimab&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T10:22:15.004Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07438496", "title": "A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "Nipocalimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of care treatment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 600, "start_date": "2026-03-05", "completion_date": "2031-11-07", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-04T10:22:15.004Z", "location_count": 36, "location_summary": "Beverly Hills, California • Fullerton, California • Hemet, California + 32 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Hemet", "state": "California" }, { "city": "La Palma", "state": "California" }, { "city": "San Leandro", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07438496" }, { "nct_id": "NCT06741969", "title": "Nipocalimab in Moderate to Severe Sjogren's Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sjogrens Syndrome" ], "interventions": [ { "name": "Nipocalimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of care treatment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 655, "start_date": "2024-12-04", "completion_date": "2029-05-18", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-04T10:22:15.004Z", "location_count": 43, "location_summary": "Chula Vista, California • Fullerton, California • La Palma, California + 37 more", "locations": [ { "city": "Chula Vista", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "La Palma", "state": "California" }, { "city": "Monterey Park", "state": "California" }, { "city": "San Leandro", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06741969" }, { "nct_id": "NCT04951622", "title": "A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Myasthenia Gravis" ], "interventions": [ { "name": "Nipocalimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Nipocalimab SC-LIV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 199, "start_date": "2021-07-15", "completion_date": "2029-03-29", "has_results": true, "last_update_posted_date": "2026-07-27", "last_synced_at": "2026-09-04T10:22:15.004Z", "location_count": 24, "location_summary": "Paradise Valley, Arizona • Scottsdale, Arizona • Los Angeles, California + 21 more", "locations": [ { "city": "Paradise Valley", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Pasadena", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04951622" }, { "nct_id": "NCT05912517", "title": "A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hemolytic Disease of the Fetus and Newborn" ], "interventions": [ { "name": "Nipocalimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 120, "start_date": "2023-12-20", "completion_date": "2029-10-08", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-04T10:22:15.004Z", "location_count": 20, "location_summary": "La Jolla, California • Los Angeles, California • Sacramento, California + 17 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05912517" }, { "nct_id": "NCT06533098", "title": "A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Thrombocytopenia, Neonatal Alloimmune" ], "interventions": [ { "name": "Nipocalimab", "type": "DRUG" }, { "name": "Intravenous immunoglobulins (IVIG)", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 50, "start_date": "2025-02-10", "completion_date": "2029-12-11", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-04T10:22:15.004Z", "location_count": 13, "location_summary": "Birmingham, Alabama • Sacramento, California • Aurora, Colorado + 10 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Sacramento", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Park Ridge", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06533098" }, { "nct_id": "NCT05265273", "title": "A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Myasthenia Gravis" ], "interventions": [ { "name": "Nipocalimab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "2 Years to 17 Years" }, "enrollment_count": 12, "start_date": "2022-07-20", "completion_date": "2029-07-02", "has_results": false, "last_update_posted_date": "2026-07-31", "last_synced_at": "2026-09-04T10:22:15.004Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT05265273" }, { "nct_id": "NCT05327114", "title": "Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Polyradiculoneuropathy, Chronic Inflammatory Demyelinating" ], "interventions": [ { "name": "Nipocalimab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 201, "start_date": "2022-09-23", "completion_date": "2028-07-11", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-04T10:22:15.004Z", "location_count": 16, "location_summary": "Centennial, Colorado • Coral Springs, Florida • Maitland, Florida + 13 more", "locations": [ { "city": "Centennial", "state": "Colorado" }, { "city": "Coral Springs", "state": "Florida" }, { "city": "Maitland", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05327114" }, { "nct_id": "NCT07217587", "title": "Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Myasthenia Gravis" ], "interventions": [ { "name": "Nipocalimab", "type": "DRUG" }, { "name": "Efgartigimod", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 115, "start_date": "2026-01-05", "completion_date": "2029-01-29", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-04T10:22:15.004Z", "location_count": 14, "location_summary": "Fullerton, California • Pomona, California • Fort Collins, Colorado + 11 more", "locations": [ { "city": "Fullerton", "state": "California" }, { "city": "Pomona", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Farmington", "state": "Connecticut" }, { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07217587" }, { "nct_id": "NCT07669077", "title": "A Study to Assess Nipocalimab Concentrations in Breast Milk of Healthy Lactating Women", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Nipocalimab", "type": "DRUG" }, { "name": "Breast Milk Sampling", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 8, "start_date": "2026-06-23", "completion_date": "2027-02-16", "has_results": false, "last_update_posted_date": "2026-08-28", "last_synced_at": "2026-09-04T10:22:15.004Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT07669077" }, { "nct_id": "NCT06028438", "title": "A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Arthritis, Rheumatoid" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Nipocalimab", "type": "DRUG" }, { "name": "Certolizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 103, "start_date": "2023-08-15", "completion_date": "2024-10-29", "has_results": true, "last_update_posted_date": "2025-10-16", "last_synced_at": "2026-09-04T10:22:15.004Z", "location_count": 10, "location_summary": "Phoenix, Arizona • Huntington Beach, California • Upland, California + 7 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Brandon", "state": "Florida" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06028438" } ] }